GERD Market Forecast (2026–2030): Demand Trends and Growth
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Gastroesophageal Reflux Disease (GERD) Market Expected To Reach Based On Its 2026 Value?
The gastroesophageal reflux disease (gerd) market size has demonstrated consistent growth over recent years. This market is projected to expand from $5.33 billion in 2025 to $5.46 billion by 2026, achieving a compound annual growth rate (CAGR) of 2.3%. Historically, this expansion has been driven by the broad application of antacids and H2 blockers, an uptick in obesity prevalence, significant consumption of processed foods, better clinical diagnosis rates, and the accessibility of generic PPIs.
The market for gastroesophageal reflux disease (GERD) is projected to experience consistent expansion over the upcoming years, reaching a valuation of $6.2 billion by 2030, driven by a compound annual growth rate (CAGR) of 3.3%. This anticipated growth during the forecast timeframe is attributable to several factors, including an increase in minimally invasive reflux procedures, a heightened need for sustained symptom management, advancements in endoscopic devices, an expanding elderly demographic, and greater patient awareness. Key trends expected over the same period encompass an increase in the long-term application of proton pump inhibitors, wider acceptance of minimally invasive GERD interventions, enhanced understanding of managing the condition through lifestyle adjustments, a broader array of endoscopic treatment alternatives, and improved diagnosis rates stemming from more effective screening.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Gastroesophageal Reflux Disease (GERD) Market?
The expanding occurrence of esophageal diseases is anticipated to drive forward the growth of the gastroesophageal reflux disease (GERD) market. Esophageal diseases refer to medical conditions impacting the esophagus, a muscular tube that links the mouth to the stomach. The management of these conditions seeks to lessen symptoms, improve quality of life, and avert complications, ultimately fostering enhanced health and well-being for those affected by gastroesophageal reflux disease. For instance, in January 2023, the American Cancer Society, a US-based professional organization, stated that around 21,560 new cases of esophageal cancer are identified each year in the United States, with 16,120 deaths resulting from the disease. This increasing prevalence of esophageal diseases thus fuels the expansion of the gastroesophageal reflux disease (GERD) market.
How Are Different Segments Classified In The Gastroesophageal Reflux Disease (GERD) Market Segment Analysis?
The gastroesophageal reflux disease (gerd) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
What Trends Are Influencing The Gastroesophageal Reflux Disease (GERD) Market?
Prominent companies operating in the gastroesophageal reflux disease (GERD) market are concentrating on launching innovative gastroesophageal reflux disease treatment devices to retain their standing in the industry. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, unveiled its new alpHaONE wireless pH-capsule reflux testing diagnostic system, which is designed for diagnosing gastroesophageal reflux disease (GERD). This system delivers up to 96 hours of monitoring data and boasts a compact design, along with enlarged buttons and a fail-safe capsule delivery system. It also incorporates a software application featuring a virtual instruction program and user-customizable symptom buttons, all intended to enhance the user experience.
Who Are The Companies Driving Activity In The Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.
Get The Full Gastroesophageal Reflux Disease (GERD) Market Report:
Which Region Leads The Gastroesophageal Reflux Disease (GERD) Market In Overall Market Size?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease (gerd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastroesophageal Reflux Disease (GERD) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2026, By The Business Research Company
Barretts Esophagus Market Report 2026
https://www.thebusinessresearchcompany.com/report/barretts-esophagus-global-market-report
Gastroesophageal Reflux Disease Therapeutics Market Report 2026
Gastroparesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
